Get the Stockscreener App
4.84
9.26%
0.41
After Hours:
4.85
0.010
+0.21%
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com South Africa
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Advances H1N1 Efficacy Study Noting - GlobeNewswire
Mangoceuticals advances in H1N1 and H5N1 studies - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies By Investing.com - Investing.com UK
Major H1N1 Treatment Success: Mangoceuticals' Novel Antiviral Shows Promise Against Bird Flu - StockTitan
Mangoceuticals Advances H1N1 Efficacy Study Noting Significant Reduction in Viral Load in Phase 1 Studies and Engages Vipragen Biosciences to Structure H5N1 Cohort for Expanded Research - Business Upturn
Mangoceuticals executes exclusive distribution agreement with Propre - MSN
Mangoceuticals Signs Exclusive Distribution Deal With Propre Energie For Dermytol - Nasdaq
Mangoceuticals, Inc. Executes Exclusive Distribution - GlobeNewswire
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol Skincare Treatment Targeting Hyperpigmentation - Marketscreener.com
Mangoceuticals, Inc. Finalizes Debt Conversion and Appointments - TipRanks
Mangoceuticals alters stockholder rights, amends bylaws - MSN
Mangoceuticals alters stockholder rights, amends bylaws By Investing.com - Investing.com Canada
Mangoceuticals, Inc. announced that it has received $0.55 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.05 million in funding - Marketscreener.com
Mangoceuticals, Inc. announced that it has received $0.3 million in funding - Marketscreener.com
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors - Defense World
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Accredited Investors - Defense World
Patent Acquisition Fuels Mangoceuticals (MGRX) Stock Surge During Extended Trading - Stocks Telegraph
Mangoceuticals Shares Rise 22%, Company Acquires Mushroom-Based Wellness and Innovations Patent - MarketWatch
Mangoceuticals Expands with Patent Acquisition in Nutraceuticals - TipRanks
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewswire
Mangoceuticals inks new service agreement, issues equity By Investing.com - Investing.com Nigeria
Mangoceuticals inks new service agreement, issues equity - Investing.com India
Mangoceuticals probes unusual stock activity post-split - Investing.com
Mangoceuticals initiates investigation into potential stock manipulation - TipRanks
Mangoceuticals probes unusual stock activity post-split By Investing.com - Investing.com UK
Mangoceuticals, Inc. Initiates Investigation into Potential - GlobeNewswire
MangoRx Launches Investigation Into Suspicious Trading Activity After Stock Split - StockTitan
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
0.42%
6.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):